StonvexLoading…
StonvexStonvexStonvexCore line items from VRSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $428.90M | $1.66B | $1.23B | $812.20M |
Operating Income | $293.60M | $1.12B | $836.20M | $551.90M |
Net Income | $214.50M | $825.70M | $619.50M | $406.70M |
EPS (Diluted) | $2.34 | $8.81 | $6.58 | $4.31 |
Total Assets | $1.30B | $1.33B | $1.40B | $1.41B |
Total Liabilities | $3.51B | $3.48B | $3.45B | $3.40B |
Cash & Equivalents | $476.70M | $307.90M | $235.40M | $314.30M |
Free Cash Flow OCF − CapEx | $265.20M | $1.07B | $783.20M | $480.20M |
Shares Outstanding | 91.10M | 91.90M | 92.90M | 93.60M |